DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-799 Cr | ₹-797 Cr | ₹-532 Cr | ₹-35 Cr | ₹-1,091 Cr |
What is the latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-799 Cr |
Mar2023 | ₹-797 Cr |
Mar2022 | ₹-532 Cr |
Mar2021 | ₹-35 Cr |
Mar2020 | ₹-1,091 Cr |
How is Cash Flow from Financing Activities of DIVIS LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-799 Cr | Negative | |
Mar2023 | ₹-797 Cr | Negative | |
Mar2022 | ₹-532 Cr | Negative | |
Mar2021 | ₹-35 Cr | Negative | |
Mar2020 | ₹-1,091 Cr | - |
Compare Cash Flow from Financing Activities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹177,096.5 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,176.0 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
CIPLA | ₹121,592.0 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,615.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,024.0 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics | |
MANKIND PHARMA | ₹98,309.9 Cr | 1.1% | -7% | 9.7% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 0.7% |
7.4% |
48.1% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses